Understanding and overcoming metformin gastrointestinal intolerance-Reference-Cited by-同舟云学术

Understanding and overcoming metformin gastrointestinal intolerance

Published:2017-02-22 Issue:4 Volume:19 Page:473-481
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Bonnet Fabrice¹,Scheen André²³^ORCID

Affiliation:

1. Department of Endocrinology, Diabetes and Nutrition; Centre Hospitalier Universitaire de Rennes; Rennes France

2. Department of Endocrinology, Diabetes and Nutrition, Division of Clinical Pharmacology, Center for Interdisciplinary Research on Medicines (CIRM); University of Liège, CHU; Liège Belgium

3. Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine; University of Liège CHU; Liège Belgium

Funder

Merck

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12854/fullpdf

Reference97 articles.

1. Chinese Diabetes Society China Guideline for Type 2 Diabetes [in Chinese] 2010 http://www.diab.net.cn/uploadfile/T2dmguideline2010.pdf

2. NICE guidelines. Type 2 diabetes in adults: management 2015 http://www.nice.org.uk/guidance/ng28/chapter/1-Recommendations#drug-treatment-2

3. International Diabetes Federation. 2012 http://www.idf.org/sites/default/files/IDF-Guideline-for-Type-2-Diabetes.pdf

4. The Royal Australian College of General Practitioners and Diabetes Australia General practice management of type 2 diabetes - 2014-15 2014 http://www.racgp.org.au/your-practice/guidelines/diabetes/

5. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2016 executive summary;Garber;Endocr Pract,2016

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving Type 2 Diabetes Care with Extended-Release Metformin: Real-Life Insights from a Physician Educational Program;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-09

2. Tirzepatide: unveiling a new dawn in dual-targeted diabetes and obesity management;Expert Review of Endocrinology & Metabolism;2024-08-28

3. Bidirectional association between type 2 diabetes and irritable bowel syndrome: A large‐scale prospective cohort study;Diabetes, Obesity and Metabolism;2024-08-20

4. A randomized controlled study of neoadjuvant metformin with chemotherapy in nondiabetic breast cancer women: The METNEO study;British Journal of Clinical Pharmacology;2024-08-07

5. The Prescription and Safety of Oral Antidiabetic Drugs in Outpatients with Type 2 Diabetes Mellitus: An Observational, Retrospective, Multicenter Study on the Role of Adherence in a Real-Life Primary Care Setting;Diabetology;2024-08-07